小剂量奥氮平联合文拉法辛对重度抑郁症急性期患者疗效的影响

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (839 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate the therapeutic effect of low-dose Olanzapine combined with Venlafaxine on acute phase of patients with acute major depression.Methods A total of 94 patients with acute major depression admitted to the Fourth People′s Hospital of Yingkou City from May 2019 to May 2020 were selected as the research subjects.They were divided into study group and reference group by random number table method,with 47 patients in each group.The reference group was treated with Venlafaxine orally,while the study group was treated with low-dose Olanzapine on the basis of Venlafaxine.The Hamilton depression scale (HAMD) scores before treatment and at 2,4,8 and 16 weeks after treatment of the two groups were compared,the clinical efficacy and total incidence of adverse reactions in the two groups were compared.Results Before treatment,there were no significant differences in HAMD scores between the two groups (P＞0.05).HAMD scores of 2,4,8 and 16 weeks after treatment in the two groups were lower than those before treatment,the differences were statistically significant (P＜0.05).The HAMD scores at 2,4,8 and 16 weeks after treatment of the study group were lower than those of the reference group,with statistical significances (P＜0.05).The total effective rate of study group was higher than that of reference group,and the difference was statistically significant(P＜0.05).There was no significant difference in the total incidence of adverse reactions between the two groups (P＞0.05).Conclusion The combination of Venlafaxine and low-dose Olanzapine in the treatment of patients with acute major depression can improve the clinical treatment effect and help to control depressive symptoms more quickly without increasing adverse reactions

Key words： Acute major depression Low-dose Olanzapine Venlafaxine Therapeutic effect

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	SUN Yan
	LIN Dongmei

Cite this article:

SUN Yan,LIN Dongmei. Therapeutic effect of low-dose Olanzapine combined with Venlafaxine on patients with acute major depression[J]. 中国当代医药, 2022, 29(7): 57-59转63.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I7/57

[1]	邬智俊，刘清莹.重度抑郁症患者家属心理健康状况及生活质量[J].中国健康心理学杂志，2018，26（3）：330-333.
[2]	王巍，冀成君，李伟，等.文拉法辛缓释胶囊联合MECT对中重度抑郁发作的效果及认知功能的影响[J].四川精神卫生，2019，32（1）：47-50.
[3]	张鑫越，张志红.理性情绪疗法联合文拉法辛治疗产后抑郁症患者的效果[J].国际精神病学杂志，2020，47（4）：132-135.
[4]	张卫华，陈兴阳，齐文耀，等.心理干预联合文拉法辛、利培酮治疗难治性抑郁症的疗效及对生活质量的影响[J].中国基层医药，2018，24（6）：720-724.
[5]	黄建海，王孟璞，余萍.草酸艾司西酞普兰联合小剂量奥氮平对抑郁症患者负性情绪及神经功能的影响[J].中国基层医药，2020，27（22）：2758-2762.
[6]	高丹青，马笑风.文拉法辛联合喹硫平治疗重度抑郁症急性期患者的疗效观察[J].实用临床医药杂志，2020，24（1）：62-65.
[7]	中华医学会精神病学分会.中国精神障碍分类与诊断标准第三版（精神障碍分类）[J].中华精神科杂志，2001，34（3）：184-188.
[8]	陈东营.文拉法辛联合帕罗西汀治疗抑郁症的临床疗效及其对TESS评分的影响[J].航空航天医学杂志，2020，31（6）：655-657.
[9]	Hamilton M.A rating scale for depression[J].J Neurol Neursurg Psychiatry，1960，23（11）：56-62.
[10]	陈健，周颖.文拉法辛缓释剂与帕罗西汀治疗抑郁症的效果比较[J].医药前沿，2019，9（17）：66-67.
[11]	曹克勇，许碧华，唐霁，等.认知行为疗法联合抗抑郁治疗难治性抑郁症疗效评估[J].现代医药卫生，2018，34（9）：1336-1337，1341.
[12]	马衡.文拉法辛联合小剂量氨磺必利对重度抑郁症患者血清IL-1β、IL-6 和TNF-α 水平的影响[J].泰山医学院学报，2018，39（1）：73-74.
[13]	庞继松.小剂量奥氮平辅助治疗抑郁障碍患者的效果及对血清神经递质和神经电生理指标的影响[J].海峡药学，2019，31（10）：161-163.
[14]	张丹丹.文拉法辛联合米氮平对临床严重抑郁患者的临床疗效及安全性评价分析[J].首都食品与医药，2019，20（14）：83-84.
[15]	肖长久，陈海珠，程国强，等.小剂量奥氮平联合文拉法辛对重度抑郁患者急性期治疗临床效果的观察[J].国际精神病学杂志，2018，45（2）：278-281.